A comparative study of tranylcypromine and paragyline.
D000293:Adolescent; D000328:Adult; D000368:Aged; D001794:Blood Pressure / Q000187:drug effects; D002746:Chlorpromazine / Q000627:therapeutic use; D002749:Chlorprothixene / Q000627:therapeutic use; D005260:Female; D006801:Humans; D008728:Methotrimeprazine / Q000627:therapeutic use; D008875:Middle Aged; D010293:Pargyline / Q000009:adverse effects / Q000627:therapeutic use*; D012559:Schizophrenia / Q000188:drug therapy*; D013881:Thioridazine / Q000627:therapeutic use; D014149:Tranquilizing Agents / Q000627:therapeutic use; D014191:Tranylcypromine / Q000009:adverse effects / Q000627:therapeutic use*; D014268:Trifluoperazine / Q000627:therapeutic use
D014149:Tranquilizing Agents; D014268:Trifluoperazine; D014191:Tranylcypromine; D008728:Methotrimeprazine; D010293:Pargyline; D002749:Chlorprothixene; D013881:Thioridazine; D002746:Chlorpromazine
Am J Psychiatry. 1962 Apr;118:933-4
13865333